FDA recall record

PBM Nutritionals Parent's Choice brand Sensitivity Premium Infant Formula recall — FDA F-1493-2023

Inadvertent release of rejected product to market

Class IIIclassification
F-1493-2023official record ID
Sep 13, 2023report date

Recall record at a glance

Official recordF-1493-2023
CategoryFood Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmPBM Nutritionals, LLC
Report dateSep 13, 2023
Recall initiation dateJun 16, 2023
QuantityN/A
LocationGeorgia, VT, United States

Official product description

Parent's Choice brand Sensitivity Premium Infant Formula, 638g, packaged in plastic tubs; and Tippy Toes brand Sensitivity Premium Infant Formula, 942g, packaged in composite cans

Why the product was recalled

Inadvertent release of rejected product to market

Distribution information

IL, AL, IA, GA, MS, IN, AR, CO, FL, VA, OH, WI, PA, NH, AZ, KS, TX, TN, NC, LA, MO, KY, DE, WI

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Telephone.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.